Yvedt L. Matory

4.0k total citations · 2 hit papers
15 papers, 3.1k citations indexed

About

Yvedt L. Matory is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Yvedt L. Matory has authored 15 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Oncology and 2 papers in Surgery. Recurrent topics in Yvedt L. Matory's work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (6 papers). Yvedt L. Matory is often cited by papers focused on CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (6 papers). Yvedt L. Matory collaborates with scholars based in United States. Yvedt L. Matory's co-authors include Steven A. Rosenberg, Stephen E. Ettinghausen, Claudia A. Seipp, Michael T. Lotze, John T. Vetto, Alfred E. Chang, Linda Muul, Eitan Shiloni, Susan F. Leitman and John M. Skibber and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Cancer.

In The Last Decade

Yvedt L. Matory

15 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

1985 2.0k citations Steven A. Rosenberg, Michael T. Lotze et al. New England Journal of Medicine profile →
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1985 488 citations Michael T. Lotze, Yvedt L. Matory et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yvedt L. Matory United States	10	2.0k	1.5k	457	331	272	15	3.1k
Joshua T. Rubin United States	19	1.8k 0.9×	1.4k 1.0×	851 1.9×	411 1.2×	264 1.0×	40	3.4k
William H. West United States	16	1.6k 0.8×	1.0k 0.7×	387 0.8×	228 0.7×	159 0.6×	36	2.6k
Gilles Thibault France	27	1.3k 0.7×	830 0.6×	446 1.0×	133 0.4×	368 1.4×	80	2.5k
Kevin C. Conlon United States	25	1.5k 0.8×	1.2k 0.8×	362 0.8×	226 0.7×	171 0.6×	58	2.5k
Geoffrey L. Stephens United States	20	2.7k 1.4×	596 0.4×	451 1.0×	318 1.0×	234 0.9×	23	3.7k
Michael S. von Bergwelt‐Baildon Germany	23	1.5k 0.8×	1.3k 0.8×	607 1.3×	138 0.4×	106 0.4×	44	2.9k
Stephen E. Ettinghausen United States	24	2.7k 1.4×	2.2k 1.5×	770 1.7×	590 1.8×	716 2.6×	34	5.1k
M A Moore United States	18	1.0k 0.5×	855 0.6×	400 0.9×	186 0.6×	165 0.6×	37	2.3k
John C. Morris United States	35	1.5k 0.8×	1.6k 1.1×	1.0k 2.2×	484 1.5×	230 0.8×	115	3.3k
Dimitri Flieger Germany	21	1.2k 0.6×	624 0.4×	457 1.0×	291 0.9×	186 0.7×	51	2.1k

Countries citing papers authored by Yvedt L. Matory

Since Specialization

Citations

This map shows the geographic impact of Yvedt L. Matory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvedt L. Matory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvedt L. Matory more than expected).

Fields of papers citing papers by Yvedt L. Matory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvedt L. Matory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvedt L. Matory. The network helps show where Yvedt L. Matory may publish in the future.

Co-authorship network of co-authors of Yvedt L. Matory

This figure shows the co-authorship network connecting the top 25 collaborators of Yvedt L. Matory. A scholar is included among the top collaborators of Yvedt L. Matory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvedt L. Matory. Yvedt L. Matory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Patenaude, Andrea Farkas, Xiaochun Li, Carolyn M. Kaelin, et al.. (2008). Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psycho-Oncology. 17(8). 831–843. 24 indexed citations

Matory, Yvedt L., David M. Dorfman, Lei Wu, et al.. (1999). Treatment of Established Tumor Is Associated with ICAM-1 Upregulation and Reversed by CD8 Depletion in a Tumor Necrosis Factor-Alpha Gene Transfected Mouse Mammary Tumor. Pathobiology. 67(4). 186–195. 5 indexed citations

Matory, Yvedt L., David M. Dorfman, Man Chen, et al.. (1999). T Cells Mediate Treatment of Six-Day-Old Cytokine-Gene-Transfected Mouse Mammary Tumor. Pathobiology. 67(1). 3–11. 6 indexed citations

Matory, Yvedt L., Man Chen, Peter S. Goedegebuure, & Timothy J. Eberlein. (1995). Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumors. Annals of Surgical Oncology. 2(6). 502–511. 6 indexed citations

Matory, Yvedt L., Michael Y. Chen, David M. Dorfman, et al.. (1995). Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection*. Surgery. 118(2). 251–256. 11 indexed citations

Goedegebuure, Peter S., et al.. (1994). Classification of CD4+ T Helper Cell Clones in Human Melanoma. Cellular Immunology. 156(1). 170–179. 15 indexed citations

Matory, Yvedt L. & Ronald H. Spiro. (1993). Wound bleeding after head and neck surgery. Journal of Surgical Oncology. 53(1). 17–19. 38 indexed citations

Matory, Yvedt L. & Michael Burt. (1993). Esophagogastrectomy: Reoperation for complications. Journal of Surgical Oncology. 54(1). 29–33. 28 indexed citations

Chang, Alfred E., Yvedt L. Matory, Andrew J. Dwyer, et al.. (1987). Magnetic Resonance Imaging Versus Computed Tomography in the Evaluation of Soft Tissue Tumors of the Extremities. Annals of Surgery. 205(4). 340–348. 98 indexed citations

10.

Matory, Yvedt L., Alfred E. Chang, Edward H. Lipford, et al.. (1987). The toxicity of recombinant human interleukin-2 in rats following intravenous infusion.. PubMed. 79(5). 537–41. 9 indexed citations

11.

Lotze, Michael T., Yvedt L. Matory, Anthony A. Rayner, et al.. (1986). Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer. 58(12). 2764–2772. 288 indexed citations

12.

Matory, Yvedt L., et al.. (1986). PROLONGED SURVIVAL OF RHESUS FETAL SKIN GRAFTS ON NONIMMUNOSUPPRESSED ALLOGENEIC HOSTS. Transplantation. 41(1). 122–124. 2 indexed citations

13.

Matory, Yvedt L., Alfred E. Chang, Edward H. Lipford, et al.. (1985). Toxicity of recombinant human interleukin-2 in rats following intravenous infusion.. PubMed. 4(4). 377–90. 46 indexed citations

14.

Lotze, Michael T., Yvedt L. Matory, Stephen E. Ettinghausen, et al.. (1985). In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.. The Journal of Immunology. 135(4). 2865–2875. 488 indexed citations breakdown →

15.

Rosenberg, Steven A., Michael T. Lotze, Linda Muul, et al.. (1985). Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer. New England Journal of Medicine. 313(23). 1485–1492. 2005 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact